Loading...
International Biotechnology Trust plc
IBT.L•LSE
Financial Services
Asset Management
£588.00
£0.00(0.00%)
International Biotechnology Trust plc (IBT.L) Financial Performance & Statements
Review International Biotechnology Trust plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
404.86%
↑ 404.86%
Operating Income Growth
470.34%
↑ 470.34%
Net Income Growth
470.62%
↑ 470.62%
Operating Cash Flow Growth
66.13%
↑ 66.13%
Operating Margin
92.23%
↑ 92.23%
Gross Margin
88.67%
↑ 88.67%
Net Profit Margin
90.66%
↑ 90.66%
ROE
13.67%
↑ 13.67%
ROIC
12.91%
↑ 12.91%
International Biotechnology Trust plc (IBT.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for International Biotechnology Trust plc stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $10.47M | $32.41M | -$4.14M | -$4.14M |
| Cost of Revenue | -$457000.00 | $5.32M | $0.00 | $0.00 |
| Gross Profit | $10.93M | $27.10M | -$4.14M | -$4.14M |
| Gross Profit Ratio | $1.04 | $0.84 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $49000.00 | $3.38M | $1.08M | $1.08M |
| Operating Expenses | $49000.00 | $2.75M | $562500.00 | $562500.00 |
| Total Costs & Expenses | $49000.00 | $2.75M | $562500.00 | $562500.00 |
| Interest Income | $0.00 | $1.26M | $341000.00 | $341000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | -$29.04M | $5.21M | $5.21M |
| EBITDA | $0.00 | -$631000.00 | $172500.00 | $172500.00 |
| EBITDA Ratio | $0.00 | -$0.02 | -$0.04 | -$0.04 |
| Operating Income | $10.52M | $29.04M | -$5.21M | -$5.21M |
| Operating Income Ratio | $1.005 | $0.90 | $1.26 | $1.26 |
| Other Income/Expenses (Net) | $89000.00 | -$631000.00 | -$4.87M | $172500.00 |
| Income Before Tax | $10.61M | $28.40M | -$5.04M | -$5.04M |
| Income Before Tax Ratio | $1.01 | $0.88 | $1.22 | $1.22 |
| Income Tax Expense | $64000.00 | $71000.00 | $34000.00 | $34000.00 |
| Net Income | $10.54M | $28.33M | -$5.07M | -$5.07M |
| Net Income Ratio | $1.007 | $0.87 | $1.23 | $1.23 |
| EPS | $0.29 | $0.72 | -$0.13 | -$0.13 |
| Diluted EPS | $0.29 | $0.72 | -$0.13 | -$0.13 |
| Weighted Avg Shares Outstanding | $36.83M | $38.88M | $40.37M | $40.37M |
| Weighted Avg Shares Outstanding (Diluted) | $36.83M | $38.88M | $40.37M | $40.37M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan